Cytokinetics, Incorporated (CYTK) shares gained 4.17% today (2023-11-30). Is it the right time to buy?

What’s happening at Cytokinetics, Incorporated (NasdaqGS:CYTK)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 4.17% (or 1.34 points) to $33.48 from its previous close of $32.14. So is it the right moment to buy?
Read more: Cytokinetics, Incorporated (CYTK) shares gained 4.17% today (2023-11-30). Is it the right time to buy?